Incretin and islet hormonal responses to fat and protein ingestion in healthy men.
@article{Carr2008IncretinAI,
title={Incretin and islet hormonal responses to fat and protein ingestion in healthy men.},
author={Richard D Carr and Marianne Olholm Larsen and Maria S{\"o}rhede Winzell and Katarina Jelic and Ola Lindgren and Carolyn F. Deacon and Bo Ahr{\'e}n},
journal={American journal of physiology. Endocrinology and metabolism},
year={2008},
volume={295 4},
pages={
E779-84
}
}Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) regulate islet function after carbohydrate ingestion. Whether incretin hormones are of importance for islet function after ingestion of noncarbohydrate macronutrients is not known. This study therefore examined integrated incretin and islet hormone responses to ingestion of pure fat (oleic acid; 0.88 g/kg) or protein (milk and egg protein; 2 g/kg) over 5 h in healthy men, aged 20-25 yr (n=12); plain water…
164 Citations
Physiology of incretins in health and disease.
- Medicine, BiologyThe review of diabetic studies : RDS
- 2011
The balance of evidence seems to suggest that alterations in secretion and or action of incretin hormones arise secondarily to the development of insulin resistance, glucose intolerance, and/or increases in body weight rather than being causative factors, and these impairments may contribute to the deterioration of glycemic control in diabetic patients.
DIABETIC STUDIES The Review of Physiology of Incretins in Health and Disease
- Medicine, Biology
- 2012
The balance of evidence seems to suggest that alterations in secretion and or action of incretin hormones arise secondarily to the development of insulin resistance, glucose intolerance, and/or increases in body weight rather than being causative factors, and these impairments may contribute to the deterioration of glycemic control in diabetic patients.
Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men
- Medicine, BiologyPloS one
- 2016
In obese males,GLP-1, GLP-2 and GIP responses to a fat-rich meal are greater than following an OGTT, and the most important explanatory variable for postprandial TG excursion was fasting triglycerides.
Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients.
- Medicine, BiologyAmerican journal of physiology. Gastrointestinal and liver physiology
- 2013
Cholecystectomized patients demonstrated a slight deterioration of postprandial glycemic control, probably because of metabolic changes unrelated to incretin secretion, suggesting that gallbladder emptying is not a prerequisite for GLP-1 release.
Dissociated incretin hormone response to protein versus fat ingestion in obese subjects
- Medicine, BiologyDiabetes, obesity & metabolism
- 2011
In obesity, protein and fat ingestion elicit similar early (30 min) incretin hormone responses, whereas 300‐min GIP secretion is more pronounced after fat than protein ingestion.
Differential responses of the incretin hormones GIP and GLP-1 to increasing doses of dietary carbohydrate but not dietary protein in lean rats.
- Medicine, BiologyAmerican journal of physiology. Gastrointestinal and liver physiology
- 2010
The dose-dependent relationships between incretin secretion and the two remaining macronutrients, carbohydrate and protein are investigated and it is found that the GIP-secreting cells were more sensitive than the GLP-1-secREting cells to changes in intestinal carbohydrate content.
On Meal Effects and DPP-4 Inhibition Islet- and Incretin Hormones in Health and Type 2 Diabetes
- Medicine, Biology
- 2020
New knowledge has been gained on the dynamic regulation of glucose homeostasis, islet and incretin hormone responses in healthy subjects and T2D subjects following meal ingestion with or without DPP-4 inhibition.
Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.
- Medicine, BiologyThe Journal of clinical endocrinology and metabolism
- 2010
Release and degradation of the two incretin hormones show dissociated changes in obesity: GLP-1 but not GIP secretion is lower after meal ingestion and oral glucose, whereas GIP but not GLp-1 metabolism is increased after Meal ingestion.
Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.
- Medicine, BiologyAmerican journal of physiology. Endocrinology and metabolism
- 2014
It is suggested that the fat content of a meal, by enhancing GLP-1 and GIP secretion, may contribute to the response to DPP-IV inhibition.
References
SHOWING 1-10 OF 34 REFERENCES
Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.
- Medicine, BiologyDigestion
- 1995
It is hypothesize that in contrast to GIP the GLP-1 release from L cells is triggered by nervous reflexes, by putative humoral factor(s) being released from the upper small intestine in addition to nutrient stimuli acting at the luminal surface of the gut.
Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.
- MedicineThe Journal of endocrinology
- 1993
The increases in circulating GLP-1(7-36)amide and GIP levels following carbohydrate or a mixed meal are consistent with their role as incretins, and the more sustained rises observed in the daytime during the 24-h study are inconsistent with an anabolic role in lipid metabolism.
Glucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice.
- Biology, MedicineEndocrinology
- 2006
Fat and protein may serve as exogenous regulators of secretion and inactivation of the incretin hormones with beneficial influences on glucose metabolism.
What do we know about the secretion and degradation of incretin hormones?
- Biology, MedicineRegulatory Peptides
- 2005
Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8.
- Medicine, BiologyThe American journal of physiology
- 1995
GIP and GLP-I-(7--36) amide are not only able to interact with elevated plasma glucose but are insulinotropic also with physiologically raised amino acid concentrations, which could play a role after the ingestion of mixed meals.
Biology of incretins: GLP-1 and GIP.
- Biology, MedicineGastroenterology
- 2007
This review focuses on the mechanisms regulating the synthesis, secretion, biological actions, and therapeutic relevance of the incretin peptides glucose-dependent insulinotropic polypeptide (GIP)…
Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005
- MedicineDiabetologia
- 2005
The incretin mimetics, administered by sc injection, have demonstrated lasting improvement in HbA1c in patients insufficiently treated with conventional oral therapy, and their use has been associated with steady weight loss for up to 2 years.
Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia
- Medicine, BiologyDiabetologia
- 2003
Glucagon secretion is dose-dependently stimulated by GIP at basal glucose concentrations, and this results underline differences between GIP and the glucagonostatic incretin GLP-1.
Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice.
- Biology, MedicineAmerican journal of physiology. Regulatory, integrative and comparative physiology
- 2004
It is concluded that GLP-1-induced insulin secretion at a low dose in mice is dependent on intact sensory nerves and therefore indirectly mediated and that this distinguishes GLP -1 from other examined insulin secretagogues.
Alpha cell function in health and disease: influence of glucagon-like peptide-1
- Medicine, BiologyDiabetologia
- 2005
Therapeutic approaches based around GLP-1 have the potential to improve both alpha cell and beta cell function, and could be of benefit in patients with a broad range of metabolic disorders.



